Tonix Pharmaceuticals Holding Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$17.64 |
Market Cap |
$7.99 M |
Shares Outstanding |
6.34 M |
Public Float |
2.32 M |
Address |
509 Madison Avenue New York New York 10022 United States |
Employees | - |
Website | http://www.tonixpharma.com |
Updated | 07/08/2019 |
Tonix Pharmaceuticals Holding Corp. operates as a clinical-stage pharmaceutical company, which engages in the development of pharmaceutical products for public health challenges. It focuses on delivering an efficacious, and safe long-term treatment for posttraumatic stress disorder. It offers TNX-102 SL, TNX-601, TNX-801, TNX-301, and TNX-701. |